NCT02256514View on ClinicalTrials.gov

Open Label Trial of Immunotherapy for Advanced Liver Cancer

PHASE2UnknownINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2019

Study Completion Date

December 31, 2019

Conditions
HCCLiver Cirrhosis
Interventions
BIOLOGICAL

Daily oral dose of hepcortespenlisimut-L

Oral therapeutic vaccine, hepcortespenlisimut-L (V5) to be given once-per-day with monthly check-up

Trial Locations (1)

Unknown

Immunitor LLC, Ulaanbaatar

Sponsors

Collaborators (1)

Immunitor Inc.
All Listed Sponsors
collaborator

Immunitor Inc.

INDUSTRY

lead

Immunitor LLC

INDUSTRY